Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fig. 1 Flow chart of study selection

Published byBaldric Horton Modified over 6 years ago

Similar presentations

Presentation on theme: "Fig. 1 Flow chart of study selection"— Presentation transcript:

1 Fig. 1 Flow chart of study selection
From: Cardiovascular events in anti-neutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis of observational studies Rheumatology (Oxford). Published online September 18, doi: /rheumatology/kex338 Rheumatology (Oxford) | © The Author Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please

2 Cardiovascular events comprising ischaemic heart disease, cerebrovascular accidents and peripheral arterial disease. From: Cardiovascular events in anti-neutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis of observational studies Rheumatology (Oxford). Published online September 18, doi: /rheumatology/kex338 Rheumatology (Oxford) | © The Author Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please

3 Fig. 3 Meta-analysis on the relative risk for ischaemic heart disease in ANCA-associated vasculitis
From: Cardiovascular events in anti-neutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis of observational studies Rheumatology (Oxford). Published online September 18, doi: /rheumatology/kex338 Rheumatology (Oxford) | © The Author Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please

4 Fig. 4 Meta-analysis on the relative risk for cerebrovascular accidents in ANCA-associated vasculitis From: Cardiovascular events in anti-neutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis of observational studies Rheumatology (Oxford). Published online September 18, doi: /rheumatology/kex338 Rheumatology (Oxford) | © The Author Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please

Download ppt "Fig. 1 Flow chart of study selection"

Similar presentations

An update on regional variation in cardiovascular mortality within Europe by Jacqueline Müller-Nordhorn, Sylvia Binting, Stephanie Roll, and Stefan N.

An update on regional variation in cardiovascular mortality within Europe by Jacqueline Müller-Nordhorn, Sylvia Binting, Stephanie Roll, and Stefan N.
Fig. 1. Flow diagram of study participants and outcomes.

Fig. 1. Flow diagram of study participants and outcomes.
From: A Regularist Approach to Mechanistic Type-Level Explanation

From: A Regularist Approach to Mechanistic Type-Level Explanation
From: An open day in the metric space

From: An open day in the metric space
Fig. 3. Plot of overall survival by adjuvant therapy for patient subgroups. (A) Patients with M0 disease (n = 411). (B) Patients receiving 36 Gy craniospinal.

Fig. 3. Plot of overall survival by adjuvant therapy for patient subgroups. (A) Patients with M0 disease (n = 411). (B) Patients receiving 36 Gy craniospinal.
Fig. 1 Flow chart of the COBRA-light trial and its extension study

Fig. 1 Flow chart of the COBRA-light trial and its extension study
Figure 1 The spatial and temporal distribution of diarrhoea rates

Figure 1 The spatial and temporal distribution of diarrhoea rates
From: Global Banking: Recent Developments and Insights from Research*

From: Global Banking: Recent Developments and Insights from Research*
Fig. 1 Graphical representation

Fig. 1 Graphical representation
Figure 2. CONSORT flow diagram.

Figure 2. CONSORT flow diagram.
From: Political Leadership and Power Redistribution

From: Political Leadership and Power Redistribution
Test characteristics of MRI-detected inflammation for the development of arthritis in CSA patients (A) and RA in UA patients (B) during 1-year follow-up.

Test characteristics of MRI-detected inflammation for the development of arthritis in CSA patients (A) and RA in UA patients (B) during 1-year follow-up.
Error bars represent the mean (s.e.).

Error bars represent the mean (s.e.).
pSS: primary SS; Scl: scleroderma.

pSS: primary SS; Scl: scleroderma.
Figure 1. Selection of papers.

Figure 1. Selection of papers.
Fig. 1 Underestimation and lack of sensitivity of T1-weighted fat-suppressed (FS) SPGR sequence in the assessment of BMLs. (A) Sagital T2-weighted.

Fig. 1 Underestimation and lack of sensitivity of T1-weighted fat-suppressed (FS) SPGR sequence in the assessment of BMLs. (A) Sagital T2-weighted.
Representative flow cytometry dot plots from a healthy individual

Representative flow cytometry dot plots from a healthy individual
Figure 1. Conceptual model of well-being related to involvement in theatre. From: Theatre Involvement and Well-Being, Age Differences, and Lessons From.

Figure 1. Conceptual model of well-being related to involvement in theatre. From: Theatre Involvement and Well-Being, Age Differences, and Lessons From.
Figure 1. Orthodontic set-up and location of LLLT or placebo-laser

Figure 1. Orthodontic set-up and location of LLLT or placebo-laser
Fig. 1 Flow of ascertainment of cases with incident childhood IgA vasculitis reported by four sources From: Incidence of IgA vasculitis in children estimated.

Fig. 1 Flow of ascertainment of cases with incident childhood IgA vasculitis reported by four sources From: Incidence of IgA vasculitis in children estimated.

Similar presentations

Ads by Google